Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats
Steve Lancel, PhD* ,
Stéphanie Tissier, MD*,
Serge Mordon, PhD*,
Xavier Marechal, PhD*,
Florence Depontieu, PhD ,
Arnaud Scherpereel, MD, PhD,
Claude Chopin, MD* and
Remi Neviere, MD, PhD*,*
* EA 2689, Université de Lille 2, Faculté de Médecine, Lille, France
Département de Physiologie, Faculté de Médecine, Lille, France
INSERM U416, Institut Pasteur de Lille, Lille, France
Manuscript received September 22, 2003;
revised manuscript received January 8, 2004,
accepted January 12, 2004.
* Reprint requests and correspondence: Dr. Remi Neviere, Département de Physiologie, Faculté de Médecine, 1, place de Verdun, Lille Cedex 59045, France.
rneviere{at}univ-lille2.fr
OBJECTIVES: The aim of this study was to test whether peroxynitrite neutralizers would reduce peroxynitrite accumulation and improve myocardial contractile dysfunction and inflammation in endotoxin-treated rats.
BACKGROUND: Release of endogenous proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha in response to endotoxin is responsible for the production of large amounts of nitric oxide (NO), which may exert detrimental effects on the myocardium in animal models, isolated hearts, and isolated cardiac myocytes. Recent studies have indicated that many of the deleterious effects of NO are mediated by peroxynitrite, a powerful oxidant generated from a fast diffusion-limited reaction of NO and superoxide anion.
METHODS: We studied the effects of peroxynitrite neutralizers, such as mercaptoethylguanidine (MEG) sodium succinate (10 mg/kg) and 5,10,15,20-tetrakis(4-sulfonatophenyl)-porphyrinato iron (III) (FeTPPS) (30 mg/kg) on peroxynitrite accumulation, in vivo endothelial cell-leukocyte activation on the mesenteric venule, and myocardial contractile dysfunction and inflammation in a model of sepsis induced by injection of endotoxin (10 mg/kg) in rats.
RESULTS: Mercaptoethylguanidine sodium succinate and FeTPPS largely prevented the accumulation of peroxynitrite as measured by plasma rhodamine fluorescence and heart nitrotyrosine staining. Interestingly, MEG sodium succinate and FeTPPS improved endotoxin-induced myocardial contractile dysfunction, which was associated with reduced degradation of nuclear factor kappa B inhibitory protein I-kappa-B, plasma TNF-alpha levels, and microvascular endothelial cell-leukocyte activation.
CONCLUSIONS: These observations suggest that the beneficial effects of MEG and FeTPPS on endotoxin-induced myocardial contractile dysfunction could be related to the unique effects of these compounds on cardiovascular inflammation processes.
|
Abbreviations and Acronyms
| | FeTPPS | = 5,10,15,20-tetrakis(4-sulfonatophenyl)-porphyrinato iron (III) | | IL | = interleukin | | iNOS | = inducible nitric oxide synthase | | L-NAME | = N-nitro-L-arginine methyl ester | | MEG | = mercaptoethylguanidine | | NF | = nuclear factor | | NO | = nitric oxide | | TNF | = tumor necrosis factor |
|
This article has been cited by other articles:
|
|
|
|
 
X.-Y. Jiao, E. Gao, Y. Yuan, Y. Wang, W. B. Lau, W. Koch, X.-L. Ma, and L. Tao
INO-4885 [5,10,15,20-Tetra[N-(benzyl-4'-carboxylate)-2-pyridinium]-21H,23H-porphine Iron(III) Chloride], a Peroxynitrite Decomposition Catalyst, Protects the Heart against Reperfusion Injury in Mice
J. Pharmacol. Exp. Ther.,
March 1, 2009;
328(3):
777 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kaiserova, X.-L. Tang, S. Srivastava, and A. Bhatnagar
Role of Nitric Oxide in Regulating Aldose Reductase Activation in the Ischemic Heart
J. Biol. Chem.,
April 4, 2008;
283(14):
9101 - 9112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Kohr, H. Wang, D. G. Wheeler, M. Velayutham, J. L. Zweier, and M. T. Ziolo
Targeting of phospholamban by peroxynitrite decreases {beta}-adrenergic stimulation in cardiomyocytes
Cardiovasc Res,
January 15, 2008;
77(2):
353 - 361.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev,
January 1, 2007;
87(1):
315 - 424.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Favory, S. Lancel, S. Tissier, D. Mathieu, B. Decoster, and R. Neviere
Myocardial Dysfunction and Potential Cardiac Hypoxia in Rats Induced by Carbon Monoxide Inhalation
Am. J. Respir. Crit. Care Med.,
August 1, 2006;
174(3):
320 - 325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Larche, S. Lancel, S. M. Hassoun, R. Favory, B. Decoster, P. Marchetti, C. Chopin, and R. Neviere
Inhibition of Mitochondrial Permeability Transition Prevents Sepsis-Induced Myocardial Dysfunction and Mortality
J. Am. Coll. Cardiol.,
July 18, 2006;
48(2):
377 - 385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Supinski and L. A. Callahan
Polyethylene Glycol-Superoxide Dismutase Prevents Endotoxin-induced Cardiac Dysfunction
Am. J. Respir. Crit. Care Med.,
June 1, 2006;
173(11):
1240 - 1247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Levrand, B. Pesse, F. Feihl, B. Waeber, P. Pacher, J. Rolli, M.-D. Schaller, and L. Liaudet
Peroxynitrite Is a Potent Inhibitor of NF-{kappa}B Activation Triggered by Inflammatory Stimuli in Cardiac and Endothelial Cell Lines
J. Biol. Chem.,
October 14, 2005;
280(41):
34878 - 34887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Pieper, V. Nilakantan, M. Chen, J. Zhou, A. K. Khanna, J. D. Henderson Jr., C. P. Johnson, A. M. Roza, and C. Szabo
Protective Mechanisms of a Metalloporphyrinic Peroxynitrite Decomposition Catalyst, WW85, in Rat Cardiac Transplants
J. Pharmacol. Exp. Ther.,
July 1, 2005;
314(1):
53 - 60.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
